1 |
Lippi G, Plebani M. A modern and pragmatic definition of Laboratory Medicine. Clin Chem Lab Med 2020;58:1171.
|
2 |
Glick M, Greenberg MS, Lockhart PB, Challacombe SJ. Burket's oral medicine. 13th ed. Hoboken: Wiley-Blackwell; 2021.
|
3 |
Olson JA, Feinberg I, Silverman S Jr, Abrams D, Greenspan JS. Serum vitamin B12, folate, and iron levels in recurrent aphthous ulceration. Oral Surg Oral Med Oral Pathol 1982;54:517-520.
DOI
|
4 |
Jurge S, Kuffer R, Scully C, Porter SR. Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Dis 2006;12:1-21.
|
5 |
Lu SY. Perception of iron deficiency from oral mucosa alterations that show a high prevalence of Candida infection. J Formos Med Assoc 2016;115:619-627.
DOI
|
6 |
McCord C, Johnson L. Oral manifestations of hematologic disease. Atlas Oral Maxillofac Surg Clin North Am 2017;25:149-162.
DOI
|
7 |
Askmark H, Wiholm BE. Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system. Acta Neurol Scand 1990;81:131-140.
|
8 |
Blackburn SC, Oliart AD, Garcia Rodriguez LA, Perez Gutthann S. Antiepileptics and blood dyscrasias: a cohort study. Pharmacotherapy 1998;18:1277-1283.
|
9 |
Chifman J, Laubenbacher R, Torti SV. A systems biology approach to iron metabolism. Adv Exp Med Biol 2014;844:201-225.
DOI
|
10 |
Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr 1987;46:329-334.
|
11 |
Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13:350-365.
DOI
|
12 |
Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004;151:1172-1181.
DOI
|
13 |
Garcia-Pola MJ, Llorente-Pendas S, Seoane-Romero JM, Berasaluce MJ, Garcia-Martin JM. Thyroid disease and oral lichen planus as comorbidity: a prospective case-control study. Dermatology 2016;232:214-219.
DOI
|
14 |
De Porras-Carrique T, Ramos-Garcia P, Aguilar-Diosdado M, Warnakulasuriya S, Gonzalez-Moles MA. Autoimmune disorders in oral lichen planus: a systematic review and meta-analysis. Oral Dis 2022. doi: 10.1111/odi.14127. [Epub ahead of print]
DOI
|
15 |
Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291.
DOI
|
16 |
Reznik DA. Oral manifestations of HIV disease. Top HIV Med 2005;13:143-148.
|
17 |
Kim MJ, Kim J, Kho HS. Comparison between burning mouth syndrome patients with and without psychological problems. Int J Oral Maxillofac Surg 2018;47:879-887.
DOI
|
18 |
Boyce HW, Bakheet MR. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol 2005;39:89-97.
|
19 |
Freudenreich O. Drug-induced sialorrhea. Drugs Today (Barc) 2005;41:411-418.
DOI
|
20 |
Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med 2019;8:76.
|
21 |
Shiboski CH, Shiboski SC, Seror R, et al. 2016 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017;76:9-16.
DOI
|
22 |
Baer AN, McAdams DeMarco M, Shiboski SC, et al. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome. Ann Rheum Dis 2015;74:1557-1561.
DOI
|
23 |
Guo YP, Wang CG, Liu X, et al. The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study. Curr Ther Res Clin Exp 2014;76:116-119.
DOI
|
24 |
Olson L, Eckerdal O, Hallonsten AL, Helkimo M, Koch G, Gare BA. Craniomandibular function in juvenile chronic arthritis. A clinical and radiographic study. Swed Dent J 1991;15:71-83.
|
25 |
Akerman S, Kopp S, Nilner M, Petersson A, Rohlin M. Relationship between clinical and radiologic findings of the temporomandibular joint in rheumatoid arthritis. Oral Surg Oral Med Oral Pathol 1988;66:639-643.
DOI
|
26 |
Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003;62:870-874.
DOI
|
27 |
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-2581.
DOI
|
28 |
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
DOI
|
29 |
Wu CY, Yang HY, Luo SF, Lai JH. From rheumatoid factor to anticitrullinated protein antibodies and anti-carbamylated protein antibodies for diagnosis and prognosis prediction in patients with rheumatoid arthritis. Int J Mol Sci 2021;22:686.
|
30 |
Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 1982;389:39-48.
DOI
|
31 |
Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-1485.
|
32 |
Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63:573-586.
DOI
|